Abstracts

Dose rationale and metrics of target exposure for tacrolimus and mycophenolate in paediatric patients undergoing solid organ transplantation

Thursday 16 October, 2025

Introduction: Tacrolimus (TAC) is an immunosuppressant prescribed often in combination with mycophenolic acid to patients who undergo organ transplantation. TAC exerts…

Read more

Modelling of tumour growth with respect to the use of anti-cancer agents

Thursday 16 October, 2025

Objectives: This project aimed to compare the performance of models recently published in the literature that characterise tumour volume over…

Read more

A semi-systematic review on the maturational physiology in exclusively breastfed infants: Growth – A contribution from the ConcePTION project

Thursday 16 October, 2025

Introduction: Physiologically-based pharmacokinetic (PBPK) models are a mechanistic model to predict pharmacokinetics (PK) based on study design and medicine- and…

Read more

Toward Personalized Salbutamol Therapy: Validating Virtual Patient-Derived Population Pharmacokinetic Model with Real-World Data

Thursday 16 October, 2025

Objectives: The variability in patients’ therapeutic responses underscores the importance of understanding pharmacokinetics (PK) and pharmacodynamics (PD) for effective drug…

Read more

Population Pharmacokinetics and Safety Assessment of Rifapentine in Chinese Children to Inform Dosing Recommendations for Latent Tuberculosis Infection

Thursday 16 October, 2025

Introduction Current treatment of latent tuberculosis infection (LTBI) include combined rifapentine (RFT) and isoniazid daily treatment for one month (1HP)…

Read more

A Quantitative System Pharmacology model for the development and optimization of mRNA vaccines.

Thursday 16 October, 2025

Introduction: The necessity of reducing time and costs in the development phase of a vaccine has been an open challenge…

Read more

Leveraging in vitro data from novel drug candidates to prioritize antibody combinations in autoimmune disease using a QSP model of IBD

Thursday 16 October, 2025

Objectives: For many autoimmune indications the treatment response has reached a ceiling effect and so novel combination treatment approaches may…

Read more

PBPK modelling based estimation of safe, and effective Molnupiravir doses for pediatric subpopulations against SARS-CoV-2

Thursday 16 October, 2025

Introduction: Although the end of COVID-19 pandemic has been declared, SARS-CoV-2 infection cases are still being reported worldwide [1]. During…

Read more

Organ-specific tumor dynamics predict survival of patients with metastatic colorectal cancer

Thursday 16 October, 2025

Objectives:  Several tumor growth inhibition (TGI) models have been developed to evaluate the longitudinal trajectories of tumor size and their…

Read more

Using Bayesian Modelling to Evaluate the Effect of a Neonatal Vancomycin Loading Dose on Therapeutic Target Attainment in a Low-Middle Income Country

Thursday 16 October, 2025

Introduction: Vancomycin, a glycopeptide antibiotic, has served as a cornerstone in treating hospital-acquired Gram-positive infections for over five decades. Recommended for…

Read more